These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9345389)

  • 1. Interferon beta in the cytokine network: an anti-inflammatory pathway.
    Billiau A
    Mult Scler; 1995; 1 Suppl 1():S2-4. PubMed ID: 9345389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of interferon beta on interferon gamma: inhibition of signal transduction in vitro and reduction of serum levels in multiple sclerosis patients.
    Revel M; Chebath J; Mangelus M; Harroch S; Moviglia GA
    Mult Scler; 1995; 1 Suppl 1():S5-11. PubMed ID: 9345390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory action of type I interferons deduced from mice expressing interferon beta.
    Boscá L; Bodelón OG; Hortelano S; Casellas A; Bosch F
    Gene Ther; 2000 May; 7(10):817-25. PubMed ID: 10845718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible role of autogenous IFN-beta for cytokine productions in human fibroblasts.
    Sano E; Ohashi K; Sato Y; Kashiwagi M; Joguchi A; Naruse N
    J Cell Biochem; 2007 Apr; 100(6):1459-76. PubMed ID: 17133359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines.
    Sega S; Wraber B; Mesec A; Horvat A; Ihan A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):255-8. PubMed ID: 15177779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon-beta on the cytokine production of astrocytes.
    Okada K; Kuroda E; Yoshida Y; Yamashita U; Suzumura A; Tsuji S
    J Neuroimmunol; 2005 Feb; 159(1-2):48-54. PubMed ID: 15652402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- versus anti-inflammatory cytokines: myth or reality.
    Cavaillon JM
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):695-702. PubMed ID: 11502077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
    Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
    Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
    Shapiro AM; Jack CS; Lapierre Y; Arbour N; Bar-Or A; Antel JP
    Arch Neurol; 2006 Sep; 63(9):1296-9. PubMed ID: 16966508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal effects of IFN-beta and IL-12 on STAT4 activation and cytokine induction in T cells.
    Fahey AJ; Robins RA; Constantinescu CS
    J Leukoc Biol; 2007 Jun; 81(6):1562-7. PubMed ID: 17351016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon gamma as a regulator of immune cell function].
    Szuster-Ciesielska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw; 1999; 53(1):23-41. PubMed ID: 10352545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.